First Republic Investment Management Inc. Has $26.01 Million Holdings in iShares Nasdaq Biotechnology ETF (IBB)

Share on StockTwits

First Republic Investment Management Inc. trimmed its stake in iShares Nasdaq Biotechnology ETF (NASDAQ:IBB) by 22.0% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 236,861 shares of the financial services provider’s stock after selling 66,715 shares during the period. First Republic Investment Management Inc. owned about 0.30% of iShares Nasdaq Biotechnology ETF worth $26,012,000 as of its most recent SEC filing.

Other large investors also recently made changes to their positions in the company. Quadrant Capital Group LLC acquired a new position in iShares Nasdaq Biotechnology ETF in the first quarter worth $111,000. Bay Colony Advisory Group Inc d b a Bay Colony Advisors acquired a new position in iShares Nasdaq Biotechnology ETF in the second quarter worth $134,000. KHP Capital LLC boosted its stake in iShares Nasdaq Biotechnology ETF by 61.1% in the second quarter. KHP Capital LLC now owns 1,450 shares of the financial services provider’s stock worth $159,000 after purchasing an additional 550 shares in the last quarter. Personal Resources Investment & Strategic Management Inc. acquired a new position in iShares Nasdaq Biotechnology ETF in the second quarter worth $205,000. Finally, Private Wealth Advisors Inc. acquired a new position in iShares Nasdaq Biotechnology ETF in the second quarter worth $201,000. Hedge funds and other institutional investors own 64.86% of the company’s stock.

iShares Nasdaq Biotechnology ETF stock opened at $117.74 on Friday. iShares Nasdaq Biotechnology ETF has a 52 week low of $100.22 and a 52 week high of $122.53.

iShares Nasdaq Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.

See Also: Book Value Per Share in Stock Trading

Want to see what other hedge funds are holding IBB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for iShares Nasdaq Biotechnology ETF (NASDAQ:IBB).

Institutional Ownership by Quarter for iShares Nasdaq Biotechnology ETF (NASDAQ:IBB)

Receive News & Ratings for iShares Nasdaq Biotechnology ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares Nasdaq Biotechnology ETF and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply